Update on atrial fibrillation catheter ablation technologies and techniques

Nature Reviews Cardiology

Volumn 10, Issue 10, 2013, Pages 599-612

  Dewire, Jane ^a   Calkins, Hugh ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; APIXABAN; DABIGATRAN; GADOLINIUM; HEPARIN; RIVAROXABAN;

ABLATION THERAPY; ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; ATRIOVENTRICULAR BLOCK; AUTONOMIC NERVOUS SYSTEM; BALLOON CATHETER; CARDIOVASCULAR CATHETER; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CRYOABLATION; DEATH; DEVICE SAFETY; ELECTROGRAPHY; ESOPHAGUS FISTULA; FOLLOW UP; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HIGH FREQUENCY VENTILATION; INTRACARDIAC ECHOCARDIOGRAPHY; LONG TERM CARE; META ANALYSIS (TOPIC); MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY VEIN; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SLEEP DISORDERED BREATHING; THERAPY EFFECT; THROMBUS; TRANSIENT ISCHEMIC ATTACK;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; PATIENT SELECTION; PULMONARY VEINS; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884592134     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.121     Document Type: Review

References (164)

1. McManus, D. D., Rienstra, M. & Benjamin, E. J. An update on the prognosis of patients with atrial fibrillation. Circulation 126, e143-e146 (2012).
2. Calkins, H. et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm 9, 632-696 (2012).
3. Chen, Y. et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation 104, 2849-2854 (2001). (Pubitemid 33126662)
4. Arora, R. et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 107, 1816-1821 (2003). (Pubitemid 36418365)
5. Kumagai, K. et al. Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter. J. Am. Coll. Cardiol. 43, 2281-2289 (2004). (Pubitemid 38757599)
6. Lin, Y. et al. Frequency analysis in different types of paroxysmal atrial fibrillation. J. Am. Coll. Cardiol. 47, 1401-1407 (2006).
7. Kalifa, J. et al. Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation. Circulation 113, 626-633 (2006).
8. Lin, Y. et al. Spatiotemporal organization of the left atrial substrate after circumferential pulmonary vein isolation of atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2, 233-241 (2009).
9. Zlochiver, S., Yamazaki, M., Kalifa, J. & Berenfeld, O. Rotor meandering contributes to irregularity in electrograms during atrial fibrillation. Heart Rhythm 5, 846-854 (2008).
10. Cox, J. L., Jaquiss, R. D. B., Schuessler, R. B. & Boineau, J. P. Modification of the maze procedure for atrial flutter and atrial fibrillation. J. Thorac. Cardiovasc. Surg. 110, 485-495 (1995).
11. Swartz, J., Pellerseis, G., Silvers, J., Patten, L. & Cervantez, D. A catheter based curative approach to atrial fibrillation in humans [abstract]. Circulation 90 (Suppl. I), 335 (1994).
12. Haissaguerre, M. et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 7, 1132-1144 (1996). (Pubitemid 27009526)
13. Gaita, F. et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation 97, 2136-2145 (1998). (Pubitemid 28262121)
14. Jais, P. et al. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol. 11, 2533-2538 (1998).
15. Pappone, C. et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 100, 1203-1208 (1999). (Pubitemid 29426596)
16. Calkins, H. Has the time come to abandon the concept that "Pulmonary vein isolation is the cornerstone of atrial fibrillation ablation"? Circ. Arrhythm. Electrophysiol. 6, 241-242 (2013).
17. Di Biase, L. et al. General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: Results from a randomized study. Heart Rhythm 8, 368-372 (2011).
18. Malcolme-Lawes, L. C. et al. Robotic assistance and general anaesthesia improve catheter stability and increase signal attenuation during atrial fibrillation ablation. Europace 15, 41-47 (2013).
19. Yamane, T. et al. Repeated provocation of timeand ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure. Circ. Arrhythm. Electrophysiol. 4, 601-608 (2011).
20. Arentz, T. et al. "Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol. 15, 1041-1047 (2004). (Pubitemid 39281534)
21. Steven, D. et al. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm 7, 323-330 (2010).
22. Hachiya, H. et al. Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 18, 392-398 (2007). (Pubitemid 46435054)
23. Jiang, C. et al. Early detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation: A comparison of ATP-induction and reassessment at 30 minutes postisolation. J. Cardiovasc. Electrophysiol. 20, 1382-1387 (2009).
24. Hutchinson, M. D. et al. Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm 10, 347-353 (2013).
25. Reddy, V. Y. et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 9, 1789-1795 (2012).
26. Corrado, A. et al. Impact of systematic isolation of superior vena cava in addition to pulmonary vein antrum isolation on the outcome of paroxysmal, persistent, and permanent atrial fibrillation ablation: results from a randomized study. J. Cardiovasc. Electrophysiol. 21, 1-5 (2010).
27. Lin, D. et al. Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 23, 806-813 (2012).
28. Di Biase, L. et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 122, 109-118 (2010).
29. Fürnkranz, A. et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J. Cardiovasc. Electrophysiol. 24, 492-497 (2013).
30. Calkins, H. et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up: a report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4, 816-861 (2007). (Pubitemid 46850611)
31. Miller, M. A. et al. Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: the importance of closing the visual gap. Europace 14, 653-660 (2012).
32. Arentz, T. et al. Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 115, 3057-3063 (2007). (Pubitemid 46956494)
33. Pappone, C. et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J. Am. Coll. Cardiol. 48, 2340-2347 (2006).
34. Wazni, O. M. et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293, 2634-2640 (2005). (Pubitemid 40744248)
35. Jaïs, P. et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118, 2498-2505 (2008).
36. Wilber, D. J. et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303, 333-340 (2010).
37. Cappato, R. et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3, 32-38 (2010).
38. Calkins, H. et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ. Arrhythm. Electrophysiol. 2, 349-361 (2009).
39. Zado, E. et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J. Cardiovasc. Electrophysiol. 19, 621-626 (2008). (Pubitemid 351858428)
40. Sawhney, N., Anousheh, R., Chen, W. C., Narayan, S. & Feld, G. K. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am. J. Cardiol. 104, 366-372 (2009).
41. Wokhlu, A. et al. Long-term outcome of atrial fibrillation ablation: Impact and predictors of very late recurrence. J. Cardiovasc. Electrophysiol. 21, 1071-1078 (2010).
42. Bertaglia, E. et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6year multicentre experience. Europace 12, 181-187 (2010).
43. Weerasooriya, R. et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J. Am. Coll. Cardiol. 57, 160-166 (2011).
44. Ouyang, F. et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5year follow-up. Circulation 122, 2368-2377 (2010).
45. Medi, C. et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J. Cardiovasc. Electrophysiol. 22, 137-141 (2011).
46. Cappato, R. et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111, 1100 -1105 (2005). (Pubitemid 40365469)
47. Cappato, R. et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J. Am. Coll. Cardiol. 53, 1798-1803 (2009).
48. Lee, G. et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J. Cardiovasc. Electrophysiol. 22, 163-168 (2011).
49. Hoyt, H. et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm 8, 1869-1874 (2011).
50. Leong-Sit, P. et al. Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ. Arrhythm. Electrophysiol. 3, 452-457 (2010).
51. Aldhoon, B., Wichterle, D., Peichl, P., Cihák, R. & Kautzner, J. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace 15, 24-32 (2013).
52. Di Biase, L. et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation 121, 2550-2556 (2010).
53. Bassiouny, M. et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ. Arrhythm. Electrophysiol. 6, 460-466 (2013).
54. Cleland, J. G., Coletta, A. P., Buga, L., Ahmed, D. & Clark, A. L. Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR. Eur. J. Heart Fail. 12, 623-629 (2010).
55. Reynolds, M. R., Walczak, J., White, S. A., Cohen, D. J. & Wilber, D. J. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ. Cardiovasc. Qual. Outcomes 3, 615-623 (2010).
56. Cosedis Nielsen, J. et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N. Engl. J. Med. 367, 1587-1595 (2012).
57. Parkash, R., Tang, A. S., Sapp, J. L. & Wells, G. Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation: a meta-analysis of the randomized controlled trials. J. Cardiovasc. Electrophysiol. 22, 729-738 (2011).
58. Hayward, R. M. et al. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: a meta-analysis. Heart Rhythm 8, 994-1000 (2011).
59. Assasi, N. et al. Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. J. Interv. Card. Electrophysiol. 35, 259-275 (2012).
60. Haïssaguerre, M. et al. Catheter ablation of longlasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol. 16, 1138-1147 (2005).
61. Rostock, T. et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm 8, 1391-1397 (2011).
62. Ammar, S. et al. Importance of sinus rhythm as endpoint of persistent atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 24, 388-395 (2013).
63. Park, Y. M., Choi, J., Lim, H. E., Park, S. W. & Kim, Y. Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation? J. Cardiovasc. Electrophysiol. 23, 1051-1058 (2012).
64. O'Neill, M. D. et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur. Heart J. 30, 1105-1112 (2009).
65. Lo, L. et al. The impact of left atrial size on longterm outcome of catheter ablation of chronic atrial fibrillation. J. Cardiovasc. Electrophysiol. 20, 1211-1216 (2009).
66. Lo, L. et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: Implications for catheter ablation strategy and long-term outcome. Heart Rhythm 6, 311-318 (2009).
67. Takahashi, Y. et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J. Am. Coll. Cardiol. 51, 1003-1010 (2008). (Pubitemid 351318134)
68. Brooks, A. G. et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 7, 835-846 (2010).
69. Nademanee, K. et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 51, 843-849 (2008). (Pubitemid 351253744)
70. Nademanee, K. et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 43, 2044-2053 (2004). (Pubitemid 38686799)
71. Haïssaguerre, M. et al. Catheter ablation of longlasting persistent atrial fibrillation: critical structures for termination. J. Cardiovasc. Electrophysiol. 16, 1125-1137 (2005).
72. Mun, H. et al. Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study. Heart 98, 480-484 (2012).
73. Dixit, S. et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ. Arrhythm. Electrophysiol. 5, 287-294 (2012).
74. Mulder, A. A., Wijffels, M. C., Wever, E. F. & Boersma, L. V. Pulmonary vein isolation and left atrial complex-fractionated atrial electrograms ablation for persistent atrial fibrillation with phased radio frequency energy and multi-electrode catheters: efficacy and safety during 12 months follow-up. Europace 13, 1695-1702 (2011).
75. Benjamin, E. et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271, 840-844 (1994).
76. Santangeli, P. et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J. Cardiovasc. Electrophysiol. 23, 687-693 (2012).
77. Piccini, J. P. et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 126, 2200-2207 (2012).
78. Bunch, T. J. et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin. Electrophysiol. 33, 146-152 (2010).
79. Haegeli, L. M. et al. Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome. J. Interv. Card. Electrophysiol. 28, 193-197 (2010).
80. Yokokawa, M. et al. The impact of age on the atrial substrate: Insights from patients with a low scar burden undergoing catheter ablation of persistent atrial fibrillation. J. Interv. Card. Electrophysiol. 34, 287-294 (2012).
81. Hao, S. et al. Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J. Interv. Card. Electrophysiol. 35, 173-182 (2012).
82. Gami, A. S. et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110, 364-367 (2004). (Pubitemid 38993843)
83. Stevenson, I. H. et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur. Heart J. 29, 1662-1669 (2008). (Pubitemid 351957544)
84. Altmann, D. R. et al. Clinical impact of screening for sleep related breathing disorders in atrial fibrillation. Int. J. Cardiol. 154, 256-258 (2012).
85. Tang, R. et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace 11, 100-105 (2009).
86. Matiello, M. et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 12, 1084-1089 (2010).
87. Chilukuri, K. et al. Predictive value of obstructive sleep apnoea assessed by the berlin questionnaire for outcomes after the catheter ablation of atrial fibrillation. Europace 11, 896-901 (2009).
88. Hoyer, F. F. et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J. Interv. Card. Electrophysiol. 29, 37-41 (2010).
89. Bitter, T. et al. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing. J. Cardiovasc. Electrophysiol. 23, 18-25 (2012).
90. Patel, D. et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ. Arrhythm. Electrophysiol. 3, 445-451 (2010).
91. Jongnarangsin, K. et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 19, 668-672 (2008).
92. Ng, C. Y. et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am. J. Cardiol. 108, 47-51 (2011).
93. Bitter, T. et al. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing. J. Cardiovasc. Electrophysiol. 23, 18-25 (2012).
94. Chilukuri, K. et al. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 21, 521-525 (2010).
95. Metzner, A. et al. One-year clinical outcome after pulmonary vein isolation using the novel endoscopic ablation system in patients with paroxysmal atrial fibrillation. Heart Rhythm 8, 988-993 (2011).
96. Metzner, A. et al. Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study. J. Cardiovasc. Electrophysiol. 24, 7-13 (2013).
97. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/show/NCT01456000 (2013).
98. Dukkipati, S. R. et al. The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies. Heart Rhythm 9, 919-925 (2012).
99. Dukkipati, S. R. et al. Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ. Arrhythm. Electrophysiol. 3, 266-273 (2010).
100. Schmidt, B. et al. Feasibility of circumferential pulmonary vein isolation using a novel endoscopic ablation system. Circ. Arrhythm. Electrophysiol. 3, 481-488 (2010).
101. Schmidt, B. et al. Worldwide experience using the endoscopic ablation system for ablation of atrial fibrillation [abstract]. Heart Rhythm 9 (Suppl.), S475-S495 (2012).
102. Mulder, A. A., Wijffels, M. C., Wever, E. F. & Boersma, L. V. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2year follow-up and predictors of failure. Europace 14, 818-825 (2012).
103. Scharf, C. et al. European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace 14, 1700-1707 (2012).
104. Scharf, C. et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J. Am. Coll. Cardiol. 54, 1450-1456 (2009).
105. Boersma, L. V., Wijffels, M. C., Oral, H., Wever, E. F. & Morady, F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm 5, 1635-1642 (2008).
106. Nardi, S. et al. Ablation of paroxysmal and persistent atrial fibrillation with multielectrode phased radiofrequency duty-cycled catheters: long-term results from a large cohort of patients. J. Cardiovasc. Med. (Hagerstown) http://dx.doi.org/10.2459/JCM.0b013e328360931a.
107. Gaita, F. et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J. Cardiovasc. Electrophysiol. 22, 961-968 (2011).
108. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/results/NCT01520532 (2013).
109. Kang, J. H. et al. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. J. Cardiovasc. Electrophysiol. 23, 1165-1170 (2012).
110. Verma, A. et al. Substrate and trigger ablation for reduction of atrial fibrillation (STAR AF): a randomized, multicentre, international trial. Eur. Heart J. 31, 1344-1356 (2010).
111. Lee, G. et al. Relationship among complex signals, short cycle length activity, and dominant frequency in patients with long-lasting persistent AF: a high-density epicardial mapping study in humans. Heart Rhythm 8, 1714-1719 (2011).
112. Saghy, L. et al. Is there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation? Heart Rhythm 9, 181-188 (2012).
113. Jadidi, A. S. et al. Functional nature of electrogram fractionation demonstrated by left atrial high-density mapping. Circ. Arrhythm. Electrophysiol. 5, 32-42 (2012).
114. Roberts-Thomson, K. C. et al. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm 6, 587-591 (2009).
115. Centurión, O. A. et al. Influence of advancing age on fractionated right atrial endocardial electrograms. Am. J. Cardiol. 96, 239-242 (2005). (Pubitemid 40978582)
116. Singh, S. M. et al. The modified ablation guided by ibutilide use in chronic atrial fibrillation (MAGIC-AF) study: clinical background and study design. J. Cardiovasc. Electrophysiol. 23, 352-358 (2012).
117. Singh, S. M. et al. Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated electrograms: preliminary assessment of a modified stepwise approach to ablation of persistent atrial fibrillation. J. Cardiovasc. Electrophysiol. 21, 608-616 (2010).
118. Pappone, C. et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109, 327-334 (2004). (Pubitemid 38133899)
119. Lemery, R., Birnie, D., Tang, A. S., Green, M. & Gollob, M. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm 3, 387-396 (2006).
120. Pokushalov, E. et al. Ganglionated plexi ablation directed by high-frequency stimulation and complex fractionated atrial electrograms for paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol. 35, 776-784 (2012).
121. Pokushalov, E. et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm 6, 1257-1264 (2009).
122. Scanavacca, M. et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation 114, 876-885 (2006). (Pubitemid 44337130)
123. Katritsis, D. et al. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am. J. Cardiol. 102, 330-334 (2008).
124. Katritsis, D. G. et al. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm 8, 672-678 (2011).
125. Po, S. S., Nakagawa, H. & Jackman, W. M. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 20, 1186-1189 (2009).
126. Calò, L. et al. Catheter ablation of right atrial ganglionated plexi in patients with vagal paroxysmal atrial fibrillation. Circ. Arrhythm. Electrophysiol. 5, 22-31 (2012).
127. Hou, Y. et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J. Am. Coll. Cardiol. 50, 61-68 (2007). (Pubitemid 46963520)
128. Hou, Y. et al. Interactive atrial neural network: determining the connections between ganglionated plexi. Heart Rhythm 4, 56-63 (2007). (Pubitemid 46002619)
129. Zhou, J. et al. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J. Cardiovasc. Electrophysiol. 18, 83-90 (2007). (Pubitemid 44952750)
130. Lu, Z. et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc. Res. 84, 245-252 (2009).
131. Pokushalov, E. et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J. Am. Coll. Cardiol. 60, 1163-1170 (2012).
132. Sahadevan, J. et al. Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations. Circulation 110, 3293-3299 (2004). (Pubitemid 39557490)
133. Chou, C. et al. Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. J. Am. Coll. Cardiol. 58, 158-166 (2011).
134. Narayan, S. M., Krummen, D. E. & Rappel, W. Clinical mapping approach to diagnose electrical rotors and focal impulse sources for human atrial fibrillation. J. Cardiovasc. Electrophysiol. 23, 447-454 (2012).
135. Narayan, S. M. et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. J. Am. Coll. Cardiol. 60, 628-636 (2012).
136. de Groot, N. M. et al. Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation 122, 1674-1682 (2010).
137. Cuculich, P. S. et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation 122, 1364-1372 (2010).
138. Vaquero, M., Calvo, D. & Jalife, J. Cardiac fibrillation: from ion channels to rotors in the human heart. Heart Rhythm 5, 872-879 (2008).
139. Skanes, A. C., Mandapati, R., Berenfeld, O., Davidenko, J. M. & Jalife, J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 98, 1236-1248 (1998). (Pubitemid 28436175)
140. Reichlin, T. & Michaud, G. F. Our approach to maximizing the durability of pulmonary vein isolation during a paroxysmal atrial fibrillation ablation procedure. J. Cardiovasc. Electrophysiol. 23, 1272-1276 (2012).
141. Datino, T. et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation 121, 963-972 (2010).
142. Arujuna, A. et al. Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging. Circ. Arrhythm. Electrophysiol. 5, 691-700 (2012).
143. Kuck, K. et al. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm 9, 18-23 (2012).
144. Hills, M. Contact force sensing RF catheters for ablation. StopAfib.org [online], http://www.stopafib.org/catheter-ablation/technology-contactforce.cfm (2011).
145. Nakagawa, H. I. et al. Controlling lesion size and incidence of steam pop by controlling contact force and radiofrequency power in canine beating heart [abstract]. Circulation 122, A15777 (2010).
146. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01385202 (2013).
147. Neuzil, P. et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ. Arrhythm. Electrophysiol. 6, 327-333 (2013).
148. Saliba, W. et al. Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J. Am. Coll. Cardiol. 51, 2407-2411 (2008). (Pubitemid 351815165)
149. Bai, R. et al. Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safety. J. Cardiovasc. Electrophysiol. 23, 820-826 (2012).
150. Pappone, C. et al. Robotic magnetic navigation for atrial fibrillation ablation. J. Am. Coll. Cardiol. 47, 1390-1400 (2006).
151. Miyazaki, S. et al. Remote magnetic navigation with irrigated tip catheter for ablation of paroxysmal atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3, 585-589 (2010).
152. Arya, A. et al. Catheter ablation of atrial fibrillation using remote magnetic catheter navigation: a case-control study. Europace 13, 45-50 (2011).
153. Bauernfeind, T. et al. The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias. Europace 13, 1015-1021 (2011).
154. Knight, N., Ayers, G. & Cohen, T. Robotic positioning of standard electrophysiology catheters: a novel approach to catheter robotics. J. Invasive Cardiol. 20, 250-253 (2008). (Pubitemid 351643275)
155. Frumkin, W. et al. Novel robotic catheter system demonstrates short learning curve [abstract BAF13]. J. Cardiovasc. Electrophysiol. 23, 682-683 (2012).
156. Oakes, R. S. et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119, 1758-1767 (2009).
157. Malcolme-Lawes, L. C. et al. Automated analysis of atrial late gadolinium enhancement imaging correlates with endocardial voltage and clinical outcomes: a two-center study. Heart Rhythm 10, 1184-1191 (2013).
158. Badger, T. J. et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ. Arrhythm. Electrophysiol. 3, 249-259 (2010).
159. Spragg, D. D. et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm 9, 2003-2009 (2012).
160. Lardo, A. C. et al. Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging. Circulation 102, 698-705 (2000). (Pubitemid 30640672)
161. Nazarian, S. et al. Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation 118, 223-229 (2008).
162. Nordbeck, P. et al. Feasibility of contrast-enhanced and nonenhanced MRI for intraprocedural and postprocedural lesion visualization in interventional electrophysiology: animal studies and early delineation of isthmus ablation lesions in patients with typical atrial flutter. Circ. Cardiovasc. Imaging 4, 282-294 (2011).
163. Hoffmann, B. A. et al. Interactive real-time mapping and catheter ablation of the cavotricuspid isthmus guided by magnetic resonance imaging in a porcine model. Eur. Heart J. 31, 450-456 (2010).
164. Vergara, G. R. et al. Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm 8, 295-303 (2011).